🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
120 Servings
Amino acid/Protein Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

500 mg
📊 Market median: 500.0mg (159 products)
Median 500.0mg This product: 500mg

Other Ingredients

Plant Cellulose organic Rice concentrate

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (90% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

🧪 Formulation Notes

Amino acid

100% natural Pure and potent Promotes feelings of well-being Maintain muscle mass Support immune function Support calcium absorption

L-Lysine capsules manufactured by Superior Labs contain 500 mg pure L-Lysine with absolutely no magnesium stearate, dioxides, preservatives or other potentially harmful artificial ingredients of any kind.

L-Lysine capsules manufactured by Superior Labs contain 500 mg pure L-Lysine with absolutely no magnesium stearate, dioxides, preservatives or other potentially harmful artificial ingredients of any kind.

This product is formulated, developed and manufactured in a FDA registered and GMP certified facility, 3rd party inspected by a leading compliance authority for superior quality assurance.

Does Not Contain: Magnesium stearate, dioxides, preservatives, or artificial ingredients of any kind.

Additional Information

Metal Safe Heavy Metal Tested Made in USA Certified GMP Facility

Product Details

UPC / SKU 8 50569 00607 0
DSLD Entry Date 2021-10-22
Product Type Amino acid/Protein
Form Capsule
Brand SuperiorLabs
DSLD ID 255999
Data Updated 2026-04-11

Research Evidence

3 Research Sources
74 Avg Quality Score
3 Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013
View all evidence for Lysine →

Compare Similar Products

View all Lysine products →